NFE2L2 and pulmonary hypertension: Resveratrol inhibits pulmonary artery smooth muscle cell proliferation and right ventricular remodeling in pulmonary hypertension by regulating Nrf2, SIRT1 pathway and HIF-1α expression (Mirhadi et al., 2021).